Ozempic and Rybelsus both treat diabetes and cause weight loss, but Ozempic is an injection and Rybelsus is a pill.

Fungal infections kill millions of people each year, and modern medicine is struggling to keep up. But researchers at ...

Hims & Hers trades at FWD EV/Sales of 3.45x and FWD EV/EBITDA of 25.85x, with FY2030 targets implying further upside for ...

Hims & Hers Health, Inc. analysis: subscription health platform growth, GLP-1 risks, and catalysts in women’s health & ...

In coming weeks, Wegovy pill will be available in four doses: a starter dose of 1.5 mg, as well as 4 mg, 9 mg, and 25 mg. As ...

There's a new pill and new ways to pay for the weight-loss drugs known as GLP-1s.

Naltrexone has long been used to treat alcohol use disorder. Now it’s gaining attention as a tool for people who want to cut ...

The compounding program is designed to elevate pharmacy technicians to nationally recognized training standards. “Compounding pharmacies thrive when their teams operate at the top of their training ...

An experimental drug compound could be a promising treatment for harmful diabetes complications, per a new study in lab mice and human cells. When you purchase through links on our site, we may earn ...

If you knew a medicine wasn’t regulated or reviewed by the U.S. Food and Drug Administration, would you still be willing to take it? My guess is that most people wouldn’t willingly put an unknown ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Emily Stewart Every time Emily publishes a story, you’ll get an alert straight to your inbox!

This article reviews the safety, efficacy, and regulatory concerns related to compounded semaglutide, with a focus on how health care providers can offer guidance and education to patients.